TAG:
clma
Specialty Progresses With CA Lab Regulators
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
CEO SUMMARY: Earlier this month California laboratory regulators found Specialty Laboratories, Inc. to be “in substantial compliance with California clinical laboratory law.” This is an important milestone in restoring the lab company to full compliance with both state and federal labor…
“July 15, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
In many states, pathologists were hit by substantial increases in the cost of malpractice. In some states, like Pennsylvania, the market for medical malpractice insurance has deteriorated substantially. In the case of AmeriPath, Inc., the nation’s largest operator of hospital-based…
Institute of Medicine Calls For 12 Medicare Lab Reforms
By Robert Michel | From the Volume VIII No. 6 – April 30, 2001 Issue
CEO SUMMARY: Since 1987, the clinical lab industry has endured almost non-stop cuts in the absolute level of Medicare reimbursement for lab testing. But the time may be ripe for laboratories to work together to effect far-reaching reforms to Medicare laboratory payment policies. Just as t…
“March 19, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 4 – March 19, 2001 Issue
It’s one more market sign of the continuing turmoil still transforming the traditional healthcare marketplace. New numbers reveal another decline in the membership of the American Medical Association (AMA). During 2000, the AMA lost 3,000 physician members. Only 290,357 physicians,…
“February 5, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 2 – February 5, 2001 Issue
This time the Clinical Laboratory Management Association (CLMA) looked in its own backyard to find a Executive Director. On Monday, February 12, Robert Neri will begin his responsibilities at CLMA. Not only does Neri have a long career in laboratory management, but he lives in the Ph…
Cheerios® Teaching Consumers Facts About Laboratory Testing
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
FOR YEARS, BOTH HOSPITAL LABS and independent commercial labs considered physicians and payers to be the primary customers for lab testing. The lab testing needs of patients as customers seldom came up when lab managers discussed how to organize and deliver their lab’s testing services. In fact, m…
“October 23, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days a…
“May 30, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
Expect an announcement this week that Pathology Consultants of America, Inc. (PCA), based in Nashville, Tennessee, has acquired PathSOURCE, Inc. of Port Chester, New York. Both are single specialty physician practice management (PPM) companies devoted exclusively to …
LabCorp Buys Two More California Laboratories
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: Laboratory Corporation of America is serving notice that it intends to increase its competitive presence in California, the largest market for diagnostic testing in the United States. It recently signed agreements to purchase two respected independent laboratory companies, on…
“March 6, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue
Interesting things are afoot at Esoterix, Inc., the Austin, Texas-based parent company for six specialty laboratories. President and CEO Charles L Dufesche, M.D. recently left. The new CEO is James McClintic. Esoterix has plans to become a public company and has been shopping its IPO…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized